A study by researchers at the University of Colorado in Aurora found that propofol scheduling did not change how providers practiced, according to an Anesthesiology News report. The university decided ...

Please provide your email address to receive an email when new articles are posted on . Altering the combined doses of dexmedetomidine and propofol impacts mortality risk in patients aged 65 years or ...

Researchers have figured out how a commonly used general anesthetic drug induces unconsciousness by causing brain activity to become increasingly unstable. The findings could lead to better anesthetic ...

The data were collected from people about to have surgery. They show that as anaesthesia takes hold, the interplay between ...

Please provide your email address to receive an email when new articles are posted on . Mortality, sedation quality and delirium in those receiving dexmedetomidine or clonidine did not differ from ...

Studies have shown that red haired-patients required more desflurane for immobility than those with dark hair, so researchers tested if the same connection occurs for propofol, according to Anesthesia ...

A 2003 study found that midazolam and propofol are particularly prone to producing sexual hallucinations (Anaesthesia, June 2003, Vol. 58:6, pp. 549-553). The Australian New Zealand College of ...

Propofol is the most commonly used drug to induce general anesthesia. Despite its frequent clinical application, it is poorly understood how propofol causes anesthesia. In a new study published in ...

Amneal has received the Food and Drug Administration’s permission for Propofol Injectable Emulsion, 200 mg/20 ml (10 mg/ml), 500 mg/50 ml (10 mg/ml) and 1,000 mg/100 mL (10 mg/ml), Single-Dose Vials.

Induction of General Anesthesia for Patients Greater than or Equal to 3 Years of Age Maintenance of General Anesthesia for Patients Greater than or Equal to 2 Months of Age Initiation and Maintenance ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (“ANDA”) approval from ...